Aster DM Healthcare Limited (NSE: ASTERDM)
412.80
+6.80 (1.67%)
Sep 6, 2024, 3:29 PM IST
Aster DM Healthcare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Net Income | - | 1,293 | 4,249 | 5,260 | 1,477 | 2,766 | Upgrade
|
Depreciation & Amortization | - | 2,200 | 1,920 | 6,278 | 6,094 | 5,747 | Upgrade
|
Other Amortization | - | - | - | 127.9 | 81.9 | 64.1 | Upgrade
|
Loss (Gain) From Sale of Assets | - | -116.3 | -57.8 | 28.1 | 44.4 | -1.8 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | - | - | - | 48.6 | Upgrade
|
Loss (Gain) From Sale of Investments | - | -338.1 | -3.1 | - | -3.1 | -1 | Upgrade
|
Loss (Gain) on Equity Investments | - | 282.2 | -12.2 | -5.4 | -35.2 | 1.9 | Upgrade
|
Stock-Based Compensation | - | 73.6 | 6.7 | -1.3 | 24.9 | 11.9 | Upgrade
|
Provision & Write-off of Bad Debts | - | 1,824 | 1,696 | 2,401 | 2,692 | 1,766 | Upgrade
|
Other Operating Activities | - | 4,704 | 381.2 | 3,071 | 3,357 | 3,603 | Upgrade
|
Change in Accounts Receivable | - | -2,219 | -3,185 | -1,824 | 359.5 | -3,266 | Upgrade
|
Change in Inventory | - | -3,030 | -1,930 | -1,446 | 945.7 | -1,487 | Upgrade
|
Change in Other Net Operating Assets | - | -11,464 | 5,993 | -748.6 | 652.7 | 2,979 | Upgrade
|
Operating Cash Flow | - | 1,578 | 18,340 | 13,140 | 15,691 | 12,233 | Upgrade
|
Operating Cash Flow Growth | - | -91.40% | 39.57% | -16.26% | 28.27% | 103.56% | Upgrade
|
Capital Expenditures | - | -7,969 | -7,169 | -4,830 | -4,043 | -5,239 | Upgrade
|
Sale of Property, Plant & Equipment | - | 468.5 | 88.8 | 40.6 | 372.1 | 225 | Upgrade
|
Cash Acquisitions | - | - | -168.4 | -153.7 | - | -2,332 | Upgrade
|
Sale (Purchase) of Intangibles | - | -86.7 | -1,310 | -649.3 | -193.9 | -69.4 | Upgrade
|
Investment in Securities | - | -1,272 | -1,180 | -144 | -125.3 | 694.9 | Upgrade
|
Other Investing Activities | - | 12.5 | 19.1 | 32 | 686.7 | 47.5 | Upgrade
|
Investing Cash Flow | - | -8,847 | -9,719 | -5,705 | -3,303 | -6,673 | Upgrade
|
Short-Term Debt Issued | - | 2,921 | 1,893 | 1,196 | - | - | Upgrade
|
Long-Term Debt Issued | - | 15,186 | - | 673.8 | 1,904 | 3,460 | Upgrade
|
Total Debt Issued | - | 18,107 | 1,893 | 1,870 | 1,904 | 3,460 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | -2,532 | -906.7 | Upgrade
|
Long-Term Debt Repaid | - | -4,812 | -6,896 | -7,033 | -8,803 | -4,727 | Upgrade
|
Total Debt Repaid | - | -4,812 | -6,896 | -7,033 | -11,335 | -5,633 | Upgrade
|
Net Debt Issued (Repaid) | - | 13,295 | -5,004 | -5,163 | -9,431 | -2,174 | Upgrade
|
Issuance of Common Stock | - | - | - | - | 7.9 | 10.4 | Upgrade
|
Repurchase of Common Stock | - | - | - | - | - | -1,200 | Upgrade
|
Other Financing Activities | - | -2,767 | -3,170 | -1,697 | -1,739 | -3,385 | Upgrade
|
Financing Cash Flow | - | 10,528 | -8,174 | -6,860 | -11,161 | -6,748 | Upgrade
|
Foreign Exchange Rate Adjustments | - | 64 | 210.3 | 72.2 | -27.9 | 89.1 | Upgrade
|
Net Cash Flow | - | 3,324 | 657.4 | 647.8 | 1,199 | -1,099 | Upgrade
|
Free Cash Flow | - | -6,391 | 11,171 | 8,310 | 11,649 | 6,994 | Upgrade
|
Free Cash Flow Growth | - | - | 34.43% | -28.66% | 66.56% | 2002.77% | Upgrade
|
Free Cash Flow Margin | - | -17.28% | 37.31% | 8.10% | 13.53% | 8.08% | Upgrade
|
Free Cash Flow Per Share | - | -12.83 | 22.44 | 16.69 | 23.40 | 13.91 | Upgrade
|
Cash Interest Paid | - | 2,100 | 1,490 | 1,225 | 1,635 | 2,001 | Upgrade
|
Cash Income Tax Paid | - | 712.6 | 589.5 | 571.2 | 110.5 | 656.8 | Upgrade
|
Levered Free Cash Flow | - | -23,368 | -4,857 | 2,217 | 8,569 | 3,023 | Upgrade
|
Unlevered Free Cash Flow | - | -22,705 | -4,325 | 3,811 | 10,395 | 4,986 | Upgrade
|
Change in Net Working Capital | - | 19,014 | -633.9 | 2,388 | -5,634 | -239.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.